SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001558370-23-010002
Filing Date
2023-05-16
Accepted
2023-05-16 07:15:25
Documents
65
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 6-K tmb-20230331x6k.htm 6-K 22845
2 EX-99.1 tmb-20230331xex99d1.htm   iXBRL EX-99.1 823962
3 EX-99.2 tmb-20230331xex99d2.htm EX-99.2 451738
  Complete submission text file 0001558370-23-010002.txt   3917674

Data Files

Seq Description Document Type Size
4 EX-101.SCH tmb-20230331.xsd EX-101.SCH 46274
5 EX-101.CAL tmb-20230331_cal.xml EX-101.CAL 40955
6 EX-101.DEF tmb-20230331_def.xml EX-101.DEF 123838
7 EX-101.LAB tmb-20230331_lab.xml EX-101.LAB 275461
8 EX-101.PRE tmb-20230331_pre.xml EX-101.PRE 215816
59 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20230331xex99d1_htm.xml XML 443924
Mailing Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK
Business Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK 31 88 166 7000
ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36622 | Film No.: 23925561
SIC: 2834 Pharmaceutical Preparations